Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction

25Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to investigate whether the VKORC1*3 (rs7294/9041 G > A), VKORC1*4 (rs17708472/6009 C > T), and CYP4F2 (rs2108622/1347 C > T) polymorphisms were associated with elevated warfarin maintenance dose requirements in patients with myocardial infarction (n = 105) from the Warfarin Aspirin Reinfarction Study (WARIS-II). We found significant associations between elevated warfarin dose requirements and VKORC1*3 and VKORC1*4 polymorphisms (P =.001 and P =.004, resp.), whereas CYP4F2 (1347 C > T) showed a weak association on higher warfarin dose requirements (P =.09). However, analysing these variant alleles in a regression analysis together with our previously reported data on VKORC1*2, CYP2C9*2 and CYP2C9*3 polymorphisms, gave no significant associations for neither VKORC1*3, VKORC1*4 nor CYP4F2 (1347 C > T). In conclusion, in patients with myocardial infarction, the individual contribution to warfarin dose requirements from VKORC1*3, VKORC1*4, and CYP4F2 (1347 C > T) polymorphisms was negligible. Our results indicate that pharmacogenetic testing for VKORC1*2, CYP2C9*2 and CYP2C9*3 is more informative regarding warfarin dose requirements than testing for VKORC1*3, VKORC1*4, and CYP4F2 (1347 C > T) polymorphisms. Copyright © 2011 Marianne K. Kringen et al.

Figures

  • Figure 1: Box plot of mean weekly warfarin maintenance dose for combinations of different VKORC1 haplotypes. The boxes represent the values from the 25th to 75th percentile. The middle lines represent the median. The vertical lines extend from the minimum values to the maximam values, excluding outliers and extreme values marked with open circles and asterisk, respectively. The P-value indicates the statistical significance of the difference in mean weekly warfarin dose between patients with or without the VKORC1∗2 haplotype (Mann-Whitney test).
  • Figure 2: Box plot of mean weekly warfarin maintenance dose for combinations of different CYP4F2 genotypes. The boxes represent the values from the 25th to 75th percentile. The middle lines represent the median. The vertical lines extend from the minimum values to the maximum values.

References Powered by Scopus

1302Citations
332Readers
Get full text
1171Citations
1017Readers

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kringen, M. K., Haug, K. B. F., Grimholt, R. M., Stormo, C., Narum, S., Opdal, M. S., … Brørs, O. (2011). Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction. Journal of Biomedicine and Biotechnology, 2011. https://doi.org/10.1155/2011/739751

Readers over time

‘11‘13‘14‘15‘16‘17‘18‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

59%

Researcher 4

24%

Professor / Associate Prof. 3

18%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 7

44%

Biochemistry, Genetics and Molecular Bi... 4

25%

Medicine and Dentistry 3

19%

Pharmacology, Toxicology and Pharmaceut... 2

13%

Save time finding and organizing research with Mendeley

Sign up for free
0